Indication
Primary Immune Regulatory Disorder
1 clinical trial
2 products
Clinical trial
Phase 2 Study BRIDGING PRE-TRANSPLANT INFLAMMATORY DAMPENING for PRIMARY IMMUNE REGULATORY DISORDERS (BRIDGE Trial)Status: Recruiting, Estimated PCD: 2027-03-01
Product
EmapalumabProduct
Fludarabine + Dexamethasone